Skip to main content
Fig. 4 | Journal of Inflammation

Fig. 4

From: Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion

Fig. 4

Correlation between the change of the aqueous flare value and improvement of BCVA or CMT at the 1st recurrence after intravitreal ranibizumab injection (IRI). a There was no significant correlation between the change of the aqueous flare value and improvement of BCVA at the 1st recurrence after IRI (ρ = 0.11, P = 0.673). b There was also no significant correlation between the change of the aqueous flare value and improvement of CMT at the 1st recurrence after IRI (ρ = 0.29, P = 0.276)

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us